113 related articles for article (PubMed ID: 20659685)
21. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
22. Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes.
Kanakkanthara A; Wilmes A; O'Brate A; Escuin D; Chan A; Gjyrezi A; Crawford J; Rawson P; Kivell B; Northcote PT; Hamel E; Giannakakou P; Miller JH
Mol Cancer Ther; 2011 Aug; 10(8):1419-29. PubMed ID: 21653684
[TBL] [Abstract][Full Text] [Related]
23. Fluorescent taxoids as probes of the microtubule cytoskeleton.
Evangelio JA; Abal M; Barasoain I; Souto AA; Lillo MP; Acuña AU; Amat-Guerri F; Andreu JM
Cell Motil Cytoskeleton; 1998; 39(1):73-90. PubMed ID: 9453715
[TBL] [Abstract][Full Text] [Related]
24. Modulation of lateral and longitudinal interdimeric interactions in microtubule models by Laulimalide and Peloruside A association: A molecular modeling approach on the mechanism of microtubule stabilizing agents.
Zúñiga MA; Alderete JB; Jaña GA; Fernandez PA; Ramos MJ; Jiménez VA
Chem Biol Drug Des; 2018 May; 91(5):1042-1055. PubMed ID: 29316292
[TBL] [Abstract][Full Text] [Related]
25. Identification of a new microtubule-interacting protein Mip-90.
González M; Cambiazo V; Maccioni RB
Eur J Cell Biol; 1995 Jun; 67(2):158-69. PubMed ID: 7664757
[TBL] [Abstract][Full Text] [Related]
26. Laulimalide induces dose-dependent modulation of microtubule behaviour in the C. elegans embryo.
Bajaj M; Srayko M
PLoS One; 2013; 8(8):e71889. PubMed ID: 23936530
[TBL] [Abstract][Full Text] [Related]
27. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
[TBL] [Abstract][Full Text] [Related]
28. Possible binding site for paclitaxel at microtubule pores.
Magnani M; Maccari G; Andreu JM; Díaz JF; Botta M
FEBS J; 2009 May; 276(10):2701-12. PubMed ID: 19459933
[TBL] [Abstract][Full Text] [Related]
29. Natural organic compounds that affect to microtubule functions.
Iwasaki S
Yakugaku Zasshi; 1998 Apr; 118(4):112-26. PubMed ID: 9564789
[TBL] [Abstract][Full Text] [Related]
30. Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanisms.
Wang Y; Yin S; Blade K; Cooper G; Menick DR; Cabral F
Biochemistry; 2006 Jan; 45(1):185-94. PubMed ID: 16388594
[TBL] [Abstract][Full Text] [Related]
31. 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.
Jiang JD; Davis AS; Middleton K; Ling YH; Perez-Soler R; Holland JF; Bekesi JG
Cancer Res; 1998 Dec; 58(23):5389-95. PubMed ID: 9850070
[TBL] [Abstract][Full Text] [Related]
32. Microtubule-stabilizing marine metabolite laulimalide and its derivatives: synthetic approaches and antitumor activity.
Mulzer J; Ohler E
Chem Rev; 2003 Sep; 103(9):3753-86. PubMed ID: 12964883
[No Abstract] [Full Text] [Related]
33. Interpreting a medium-resolution model of tubulin: comparison of zinc-sheet and microtubule structure.
Wolf SG; Nogales E; Kikkawa M; Gratzinger D; Hirokawa N; Downing KH
J Mol Biol; 1996 Oct; 262(4):485-501. PubMed ID: 8893858
[TBL] [Abstract][Full Text] [Related]
34. The bound conformation of microtubule-stabilizing agents: NMR insights into the bioactive 3D structure of discodermolide and dictyostatin.
Canales A; Matesanz R; Gardner NM; Andreu JM; Paterson I; Díaz JF; Jiménez-Barbero J
Chemistry; 2008; 14(25):7557-69. PubMed ID: 18449868
[TBL] [Abstract][Full Text] [Related]
35. Biomimetic transannular oxa-conjugate addition approach to the 2,6-disubstituted dihydropyran of laulimalide yields an unprecedented transannular oxetane.
Houghton SR; Furst L; Boddy CN
J Org Chem; 2009 Feb; 74(4):1454-63. PubMed ID: 19159194
[TBL] [Abstract][Full Text] [Related]
36. The assembly-inducing laulimalide/peloruside a binding site on tubulin: molecular modeling and biochemical studies with [³H]peloruside A.
Nguyen TL; Xu X; Gussio R; Ghosh AK; Hamel E
J Chem Inf Model; 2010 Nov; 50(11):2019-28. PubMed ID: 21028850
[TBL] [Abstract][Full Text] [Related]
37. IL-1beta epitope mapping using site-directed mutagenesis and hydrogen-deuterium exchange mass spectrometry analysis.
Lu J; Witcher DR; White MA; Wang X; Huang L; Rathnachalam R; Beals JM; Kuhstoss S
Biochemistry; 2005 Aug; 44(33):11106-14. PubMed ID: 16101294
[TBL] [Abstract][Full Text] [Related]
38. Methods for studying microtubule binding site interactions: zampanolide as a covalent binding agent.
Field JJ; Calvo E; Northcote PT; Miller JH; Altmann KH; Díaz JF
Methods Cell Biol; 2013; 115():303-25. PubMed ID: 23973080
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the β-tubulin binding site for peloruside A confer resistance by targeting a cleft significant in side chain binding.
Begaye A; Trostel S; Zhao Z; Taylor RE; Schriemer DC; Sackett DL
Cell Cycle; 2011 Oct; 10(19):3387-96. PubMed ID: 21926482
[TBL] [Abstract][Full Text] [Related]
40. Total synthesis of the microtubule-stabilizing agent (-)-laulimalide.
Paterson I; De Savi C; Tudge M
Org Lett; 2001 Oct; 3(20):3149-52. PubMed ID: 11574017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
